Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongmei Bai

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Microbiology|July 6, 2019
Anti-outer Membrane Vesicle Antibodies Increase Antibiotic Sensitivity of Pan-Drug-Resistant <i>Acinetobacter baumannii</i>Weiwei Huang, Qishu Zhang, Weiran Li, et al.
Scientific Reports|November 17, 2016
Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infectionWeiwei Huang, Shijie Wang, Yufeng Yao, et al.
Scientific Reports|February 9, 2016
Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumanniiWeiwei Huang, Yufeng Yao, Shijie Wang, et al.
Human Vaccines & Immunotherapeutics|October 20, 2017
Exogenous murine antimicrobial peptide CRAMP significantly exacerbates Ovalbumin-induced airway inflammation but ameliorates oxazolone-induced intestinal colitis in BALB/c miceYang Li, Xiaojie Chu, Cunbao Liu, et al.
Biochemical and Biophysical Research Communications|December 25, 2025
LOXL2 and SYVN1 cooperate across cellular compartments to drive liver hepatocellular carcinoma progressionRui Yan, Xiaoli Jiang, Rui Shi, et al.
Journal of Nanobiotechnology|June 8, 2025
Tumor microenvironment remodeling with a telomere-targeting agent and its cooperative antitumor effects with a nanovaccineJing Bai, Mengzhen Wang, Yiming Luo, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 3, 2020
A therapeutic HPV16 E7 vaccine in combination with active anti-FGF-2 immunization synergistically elicits robust antitumor immunity in miceHanghang Xie, Congyan Shu, Hongmei Bai, et al.
ACS Applied Materials & Interfaces|November 20, 2020
Employing ATP as a New Adjuvant Promotes the Induction of Robust Antitumor Cellular Immunity by a PLGA Nanoparticle VaccineQishu Zhang, Weiwei Huang, Mingcui Yuan, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 12, 2021
A Novel Immunomodulator Delivery Platform Based on Bacterial Biomimetic Vesicles for Enhanced Antitumor ImmunityLiangqun Hua, Zhongqian Yang, Weiran Li, et al.
Oncology Letters|June 5, 2023
Lanosterol synthase loss of function decreases the malignant phenotypes of HepG2 cells by deactivating the Src/MAPK signaling pathwayXiaomei Sun, Jun Zhang, Hui Liu, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Microbiology|July 6, 2019
Anti-outer Membrane Vesicle Antibodies Increase Antibiotic Sensitivity of Pan-Drug-Resistant <i>Acinetobacter baumannii</i>Weiwei Huang, Qishu Zhang, Weiran Li, et al.
Scientific Reports|November 17, 2016
Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infectionWeiwei Huang, Shijie Wang, Yufeng Yao, et al.
Scientific Reports|February 9, 2016
Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumanniiWeiwei Huang, Yufeng Yao, Shijie Wang, et al.
Human Vaccines & Immunotherapeutics|October 20, 2017
Exogenous murine antimicrobial peptide CRAMP significantly exacerbates Ovalbumin-induced airway inflammation but ameliorates oxazolone-induced intestinal colitis in BALB/c miceYang Li, Xiaojie Chu, Cunbao Liu, et al.
Biochemical and Biophysical Research Communications|December 25, 2025
LOXL2 and SYVN1 cooperate across cellular compartments to drive liver hepatocellular carcinoma progressionRui Yan, Xiaoli Jiang, Rui Shi, et al.
Journal of Nanobiotechnology|June 8, 2025
Tumor microenvironment remodeling with a telomere-targeting agent and its cooperative antitumor effects with a nanovaccineJing Bai, Mengzhen Wang, Yiming Luo, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 3, 2020
A therapeutic HPV16 E7 vaccine in combination with active anti-FGF-2 immunization synergistically elicits robust antitumor immunity in miceHanghang Xie, Congyan Shu, Hongmei Bai, et al.
ACS Applied Materials & Interfaces|November 20, 2020
Employing ATP as a New Adjuvant Promotes the Induction of Robust Antitumor Cellular Immunity by a PLGA Nanoparticle VaccineQishu Zhang, Weiwei Huang, Mingcui Yuan, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 12, 2021
A Novel Immunomodulator Delivery Platform Based on Bacterial Biomimetic Vesicles for Enhanced Antitumor ImmunityLiangqun Hua, Zhongqian Yang, Weiran Li, et al.
Oncology Letters|June 5, 2023
Lanosterol synthase loss of function decreases the malignant phenotypes of HepG2 cells by deactivating the Src/MAPK signaling pathwayXiaomei Sun, Jun Zhang, Hui Liu, et al.
Pageof 5